Groupe de Pathologie Infectieuse Pédiatrique, Société Française de Pédiatrie, Paris, France.
Pediatr Infect Dis J. 2010 Jul;29(7):618-23. doi: 10.1097/INF.0b013e3181d3ce32.
Neisseria meningitidis meningitis represents approximately one-half of the meningococcal cases in French children. To explore the contribution of bacterial typing in improving the management of cases, we aimed to describe clinical characteristics and mortality of meningococcal meningitis in children reported to the multicenter survey system, GPIP/ACTIV, in association with phenotypes/genotypes of bacterial isolates.
From 2001 to 2005, 259 pediatric wards and 168 microbiology laboratories enrolled all children with bacterial meningitis. Risk factors, vaccination status, signs and symptoms, cerebrospinal fluid analysis, treatments and case fatality rate were recorded.
A total of 962 cases of Neisseria meningitidis meningitis among a total of 2131 bacterial meningitis (45%) were recorded (mean age, 4.5 +/- 4.7 years). Serogroup distribution of the isolates was 62.3%, 33.7%, 2.9%, 0.6%, and 0.6% for serogroups B, C, W135, A and Y, respectively. The major clonal complexes were ST-41/44 (32.2%), ST-11 (21.9%), ST-32 (20.8%), ST-8 (8.2%), and ST-269 (4.9%). Despite global heterogeneity of the isolates, 2 phenotypes/genotypes were of interest. Isolates of the phenotype/genotype B:14:P1.7,16/ST-32 (56% clustered in the region of Haute Normandie) were observed in older children (8.6 years) and were associated with a higher case fatality rate (12%) than were other phenotypes of serogroup B. The phenotype/genotype C:2a:P1.5/ST-11 was found in 26.3% of serogroup C cases and was possibly associated with a higher mortality among serogroup C (9.9% for C and 5.9% for B, P = 0.04).
This large survey provides data that could be important for implementation of future vaccines. Typing of meningococcal isolates could contribute to an understanding of prognosis in meningococcal meningitis.
脑膜炎奈瑟菌脑膜炎约占法国儿童中脑膜炎奈瑟菌病例的一半。为了探讨细菌分型在改善病例管理方面的作用,我们旨在描述多中心调查系统 GPIP/ACTIV 报告的儿童中脑膜炎奈瑟菌脑膜炎的临床特征和死亡率,并将其与细菌分离株的表型/基因型相关联。
2001 年至 2005 年,259 个儿科病房和 168 个微生物学实验室招募了所有患有细菌性脑膜炎的儿童。记录了危险因素、疫苗接种情况、体征和症状、脑脊液分析、治疗和病死率。
在 2131 例细菌性脑膜炎(45%)中记录了 962 例脑膜炎奈瑟菌脑膜炎(平均年龄为 4.5±4.7 岁)。分离株的血清群分布分别为血清群 B、C、W135、A 和 Y 为 62.3%、33.7%、2.9%、0.6%和 0.6%。主要克隆复合体为 ST-41/44(32.2%)、ST-11(21.9%)、ST-32(20.8%)、ST-8(8.2%)和 ST-269(4.9%)。尽管分离株存在全球异质性,但有 2 种表型/基因型值得关注。表型/基因型 B:14:P1.7,16/ST-32(56%聚类在诺曼底地区)在年龄较大的儿童中观察到(8.6 岁),且病死率(12%)高于其他血清群 B 表型。表型/基因型 C:2a:P1.5/ST-11 见于 26.3%的 C 群病例,可能与 C 群死亡率较高有关(C 群为 9.9%,B 群为 5.9%,P=0.04)。
这项大型调查提供的资料可能对未来疫苗的实施很重要。脑膜炎奈瑟菌分离株的分型有助于了解脑膜炎奈瑟菌脑膜炎的预后。